Overview

Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis

Status:
Unknown status
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
To determine the cumulative incidence of total hip replacement, time to event after treatment with Fosamax or placebo during the study peroid
Phase:
Phase 4
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Collaborators:
Merck Sharp & Dohme Corp.
National Cheng-Kung University Hospital
National Taiwan University Hospital
Treatments:
Alendronate